CVS Stock Cash Flow Statements

CVS Health Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

CVS Health Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-09-30	2018-06-30	2018-03-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2008-09-27	2008-06-28	2008-03-29	2007-09-29	2007-06-30	2007-03-31

cash flows from operating activities:
cash receipts from customers	95,691,000,000	90,809,000,000	93,457,000,000	90,810,000,000	88,731,000,000	84,997,000,000	85,164,000,000	84,733,000,000	87,769,000,000	87,798,000,000	78,267,000,000	83,626,000,000	77,577,000,000	74,192,000,000	75,115,000,000	72,483,000,000	70,134,000,000	66,487,000,000	68,773,000,000	66,336,000,000	65,467,000,000	63,751,000,000	63,874,000,000	63,711,000,000	61,935,000,000	58,873,000,000	44,298,000,000	44,608,000,000	43,369,000,000	44,712,000,000	44,430,000,000	43,913,000,000	44,221,000,000	42,842,000,000	41,482,000,000	37,310,000,000	36,444,000,000	34,570,000,000	32,884,000,000	32,427,000,000	30,505,000,000	28,962,000,000	28,428,000,000	28,018,000,000	26,819,000,000	28,437,000,000	29,207,000,000
cash paid for inventory, prescriptions dispensed and health services rendered	-52,765,000,000	-48,433,000,000	-52,257,000,000	-54,624,000,000	-46,021,000,000	-44,824,000,000	-55,797,000,000
insurance benefits paid	-30,367,000,000	-28,477,000,000	-29,107,000,000	-27,872,000,000	-27,591,000,000	-24,894,000,000	-22,439,000,000	-20,550,000,000	-21,351,000,000	-19,757,000,000	-18,294,000,000	-17,514,000,000	-17,304,000,000	-16,616,000,000	-16,633,000,000	-15,720,000,000	-15,789,000,000	-15,456,000,000	-14,903,000,000	-13,738,000,000	-12,180,000,000	-14,303,000,000	-13,430,000,000	-12,820,000,000	-13,041,000,000	-12,951,000,000
cash paid to other suppliers and employees	-9,940,000,000	-8,690,000,000	-9,888,000,000	-7,809,000,000	-11,447,000,000	-9,677,000,000	-8,697,000,000	-8,352,000,000	-7,728,000,000	-9,958,000,000	-10,294,000,000	-7,249,000,000	-6,150,000,000	-8,969,000,000	-9,812,000,000	-6,940,000,000	-6,630,000,000	-8,270,000,000	-7,578,000,000	-7,497,000,000	-6,501,000,000	-8,187,000,000	-7,521,000,000	-6,914,000,000	-7,094,000,000	-7,403,000,000	-3,834,000,000	-4,200,000,000	-4,271,000,000	-4,230,000,000	-3,177,000,000	-3,823,000,000	-4,010,000,000	-4,121,000,000	-2,961,000,000	-3,305,000,000	-3,773,000,000	-4,162,000,000	-3,480,000,000	-3,591,000,000	-4,196,000,000	-3,308,000,000	-3,563,000,000	-3,889,000,000			-3,751,000,000			-3,342,000,000	-3,217,000,000	-3,213,000,000	-3,916,000,000	-3,510,900,000	-2,845,600,000	-2,949,400,000	-2,989,100,000	-1,295,800,000	-1,937,700,000	-2,510,000,000
interest and investment income received	475,000,000	497,000,000	447,000,000	449,000,000	432,000,000	407,000,000	410,000,000	373,000,000	375,000,000	426,000,000	699,000,000	127,000,000	1,000,000	199,000,000	161,000,000	188,000,000	172,000,000	222,000,000	272,000,000	227,000,000	189,000,000	206,000,000	199,000,000	244,000,000	262,000,000	250,000,000
interest paid	-472,000,000	-1,012,000,000	-518,000,000	-999,000,000	-349,000,000	-1,043,000,000	-369,000,000	-918,000,000	-358,000,000	-773,000,000	-303,000,000	-786,000,000	-368,000,000	-782,000,000	-374,000,000	-832,000,000	-387,000,000	-876,000,000	-387,000,000	-1,110,000,000	-279,000,000	-1,128,000,000	-279,000,000	-1,173,000,000	-379,000,000	-1,123,000,000	-1,199,000,000	-15,000,000	-545,000,000	-330,000,000	-211,000,000	-328,000,000	-339,000,000	-237,000,000	-378,000,000	-112,000,000	-224,000,000	-87,000,000	-127,000,000	-227,000,000	-104,000,000	-102,000,000	-163,000,000	-104,000,000			-128,000,000			-150,000,000	-155,000,000	-129,000,000	-155,000,000	-125,400,000	-116,300,000	-142,500,000	-124,600,000	-119,700,000	-91,500,000	-109,700,000
income taxes paid	-725,000,000	-138,000,000	-274,000,000	-700,000,000	-666,000,000	-63,000,000	-908,000,000	-837,000,000	-1,704,000,000	-75,000,000	-1,046,000,000	-1,183,000,000	-1,791,000,000	-96,000,000	-798,000,000	-845,000,000	-1,508,000,000	-44,000,000	-564,000,000	-2,135,000,000	-165,000,000	-65,000,000	-512,000,000	-729,000,000	-1,423,000,000	-53,000,000	-560,000,000	-1,298,000,000	-53,000,000	-506,000,000	-1,477,000,000	-57,000,000	-432,000,000	-1,601,000,000	-161,000,000	-678,000,000	-1,563,000,000	-64,000,000	-838,000,000	-1,413,000,000	-70,000,000	-683,000,000	-1,414,000,000	-116,000,000			-28,000,000			-169,000,000	-549,000,000	-1,029,000,000	-207,000,000	-463,400,000	-470,700,000	-774,300,000	-13,600,000	-626,800,000	-662,200,000	-54,600,000
net cash from operating activities	1,897,000,000	4,556,000,000	1,860,000,000	-745,000,000	3,089,000,000	4,903,000,000	-2,636,000,000	2,716,000,000	5,908,000,000	7,438,000,000	-1,952,000,000	9,123,000,000	5,443,000,000	3,563,000,000	4,005,000,000	5,521,000,000	5,847,000,000	2,892,000,000	3,567,000,000	1,874,000,000	7,119,000,000	3,305,000,000	2,634,000,000	2,928,000,000	5,338,000,000	1,948,000,000	1,097,000,000	2,934,000,000	2,355,000,000	2,611,000,000	1,999,000,000	3,533,000,000	3,925,000,000	1,611,000,000	2,412,000,000	1,820,000,000	1,037,000,000	1,984,000,000	1,645,000,000	897,000,000	2,172,000,000	1,703,000,000	902,000,000	1,640,000,000	923,000,000	1,231,000,000	2,786,000,000	1,962,000,000	1,207,000,000	1,866,000,000	1,292,000,000	652,000,000	1,060,000,000	907,400,000	786,200,000	651,300,000	740,800,000	445,500,000	719,500,000	707,700,000
capex	-607,000,000	-743,000,000	-768,000,000	-670,000,000	-638,000,000	-705,000,000	-911,000,000	-545,000,000	-591,000,000	-984,000,000	-688,000,000	-580,000,000	-408,000,000	-1,051,000,000	-597,000,000	-608,000,000	-486,000,000	-829,000,000	-713,000,000	-534,000,000	-448,000,000	-742,000,000	-567,000,000	-601,000,000	-573,000,000	-716,000,000	-540,000,000	-430,000,000	-482,000,000	-524,000,000	-431,000,000	-457,000,000	-505,000,000	-504,000,000	-598,000,000	-548,000,000	-523,000,000	-419,000,000	-545,000,000	-503,000,000	-388,000,000	-526,000,000	-486,000,000	-318,000,000	0	0	-376,000,000	0	0	-309,000,000	-513,000,000	-465,000,000	-401,000,000	-661,200,000	-527,900,000	-555,000,000	-400,300,000	-454,700,000	-466,100,000	-311,900,000
free cash flows	1,290,000,000	3,813,000,000	1,092,000,000	-1,415,000,000	2,451,000,000	4,198,000,000	-3,547,000,000	2,171,000,000	5,317,000,000	6,454,000,000	-2,640,000,000	8,543,000,000	5,035,000,000	2,512,000,000	3,408,000,000	4,913,000,000	5,361,000,000	2,063,000,000	2,854,000,000	1,340,000,000	6,671,000,000	2,563,000,000	2,067,000,000	2,327,000,000	4,765,000,000	1,232,000,000	557,000,000	2,504,000,000	1,873,000,000	2,087,000,000	1,568,000,000	3,076,000,000	3,420,000,000	1,107,000,000	1,814,000,000	1,272,000,000	514,000,000	1,565,000,000	1,100,000,000	394,000,000	1,784,000,000	1,177,000,000	416,000,000	1,322,000,000	923,000,000	1,231,000,000	2,410,000,000	1,962,000,000	1,207,000,000	1,557,000,000	779,000,000	187,000,000	659,000,000	246,200,000	258,300,000	96,300,000	340,500,000	-9,200,000	253,400,000	395,800,000
cash flows from investing activities:
proceeds from sales and maturities of investments	3,332,000,000	3,534,000,000	2,719,000,000	3,216,000,000	2,265,000,000	2,153,000,000	2,182,000,000	1,907,000,000	1,749,000,000	1,891,000,000	1,194,000,000	1,175,000,000	1,790,000,000	2,570,000,000	1,687,000,000	1,612,000,000	1,770,000,000	2,177,000,000	2,677,000,000	1,080,000,000	1,422,000,000	1,288,000,000	1,433,000,000	1,830,000,000	1,800,000,000	1,986,000,000
purchases of investments	-3,634,000,000	-3,552,000,000	-2,514,000,000	-5,896,000,000	-3,236,000,000	-3,545,000,000	-2,418,000,000	-2,126,000,000	-2,141,000,000	-2,358,000,000	-1,307,000,000	-1,429,000,000	-1,536,000,000	-3,474,000,000	-2,546,000,000	-1,847,000,000	-2,439,000,000	-3,131,000,000	-3,262,000,000	-2,689,000,000	-2,153,000,000	-1,535,000,000	-1,523,000,000	-1,949,000,000	-2,015,000,000	-2,047,000,000
purchases of property and equipment	-607,000,000	-743,000,000	-768,000,000	-670,000,000	-638,000,000	-705,000,000	-911,000,000	-545,000,000	-591,000,000	-984,000,000	-688,000,000	-580,000,000	-408,000,000	-1,051,000,000	-597,000,000	-608,000,000	-486,000,000	-829,000,000	-713,000,000	-534,000,000	-448,000,000	-742,000,000	-567,000,000	-601,000,000	-573,000,000	-716,000,000	-540,000,000	-430,000,000	-482,000,000	-524,000,000	-431,000,000	-457,000,000	-505,000,000	-504,000,000	-598,000,000	-548,000,000	-523,000,000	-419,000,000	-545,000,000	-503,000,000	-388,000,000	-526,000,000	-486,000,000	-318,000,000			-376,000,000			-309,000,000
acquisitions	-119,000,000	-20,000,000	-10,000,000	-12,000,000	-48,000,000	-25,000,000	-120,000,000	-18,000,000	-9,380,000,000	-7,094,000,000	-8,000,000	-6,000,000	-118,000,000	-7,000,000	-11,000,000	-27,000,000	-24,000,000	-84,000,000	-38,000,000	-60,000,000	-155,000,000	-613,000,000	-83,000,000	-111,000,000	-126,000,000	-124,000,000
other	4,000,000	19,000,000	26,000,000	15,000,000	32,000,000	28,000,000	25,000,000	11,000,000	1,000,000	31,000,000	11,000,000	20,000,000	85,000,000	-31,000,000	27,000,000	23,000,000				-1,000,000	1,000,000	5,000,000	26,000,000	2,000,000	4,000,000	10,000,000							-2,000,000	0	-4,000,000
net cash from investing activities	-1,024,000,000	-762,000,000	-547,000,000	-3,347,000,000	-1,625,000,000	-2,094,000,000	-1,242,000,000	-771,000,000	-10,362,000,000	-8,514,000,000	-119,000,000	-805,000,000	-2,130,000,000	-1,993,000,000	-1,440,000,000	-847,000,000	-1,107,000,000	-1,867,000,000	-1,234,000,000	-1,370,000,000	-1,333,000,000	-1,597,000,000	-709,000,000	-829,000,000	-910,000,000	-891,000,000	-634,000,000	-621,000,000	-131,000,000	-434,000,000	-620,000,000	-554,000,000	-421,000,000	-598,000,000	-633,000,000	-9,910,000,000	-546,000,000	-544,000,000	-349,000,000	-625,000,000	-2,560,000,000	-529,000,000	-526,000,000	-567,000,000			-443,000,000			-299,000,000	-508,000,000	-483,000,000	-397,000,000	-437,300,000	-410,400,000	-515,900,000	-346,800,000	-346,200,000	-441,700,000	-2,263,800,000
cash flows from financing activities:
commercial paper borrowings (repayments)	1,780,000,000	-859,000,000	1,319,000,000	800,000,000	-2,719,000,000	2,519,000,000
proceeds from issuance of long-term debt			2,954,000,000	0			0	0	4,947,000,000	5,951,000,000					0				2,039,000,000	3,973,000,000	0	3,946,000,000	278,000,000				0	0	39,376,000,000				0															0
repayments of long-term debt	-19,000,000	-743,000,000	-3,067,000,000	-1,669,000,000	-19,000,000	-18,000,000	-432,000,000	-947,000,000	-1,425,000,000	-362,000,000	-16,000,000	-2,666,000,000	-1,515,000,000	-14,000,000	-2,431,000,000	-2,400,000,000	-2,374,000,000	-3,049,000,000	-5,138,000,000	-9,477,000,000	-8,000,000	-1,008,000,000	14,000,000	-6,451,000,000	-1,017,000,000	-882,000,000							-1,606,000,000			-2,348,000,000			-3,045,000,000								-52,000,000			-301,000,000	-351,000,000
repurchase of common stock			0	1,000,000	3,000,000	-3,027,000,000	1,000,000	3,000,000	2,000,000	-2,018,000,000	-1,500,000,000	0	0	-2,000,000,000																-400,000,000	-340,000,000	-3,621,000,000	-40,000,000	-1,894,000,000	-2,066,000,000	-937,000,000	-927,000,000	-2,007,000,000	-800,000,000	-1,200,000,000	-801,000,000	-1,524,000,000	-355,000,000	-393,000,000			-810,000,000			-467,000,000	0	-613,000,000	-887,000,000		0			-700,000
dividends paid	-866,000,000	-840,000,000	-838,000,000	-837,000,000	-858,000,000	-840,000,000	-779,000,000	-779,000,000	-795,000,000	-779,000,000	-719,000,000	-726,000,000	-740,000,000	-722,000,000	-660,000,000	-659,000,000	-650,000,000	-656,000,000	-644,000,000	-665,000,000	-663,000,000	-652,000,000	-651,000,000	-646,000,000	-657,000,000	-649,000,000	-510,000,000	-510,000,000	-508,000,000	-511,000,000	-512,000,000	-516,000,000	-455,000,000	-459,000,000	-470,000,000	-391,000,000	-395,000,000	-399,000,000	-324,000,000	-322,000,000	-325,000,000	-276,000,000	-276,000,000	-277,000,000			-211,000,000			-171,000,000	-119,000,000	-119,000,000	-122,000,000	-110,100,000	-98,400,000	-86,200,000	-85,900,000	-88,200,000	-92,100,000	-40,300,000
proceeds from exercise of stock options	47,000,000	144,000,000	19,000,000	114,000,000	25,000,000	203,000,000	35,000,000	122,000,000	24,000,000	96,000,000	41,000,000	162,000,000	51,000,000	297,000,000	109,000,000	110,000,000	118,000,000	212,000,000	15,000,000	83,000,000	12,000,000	154,000,000	27,000,000	72,000,000	10,000,000	101,000,000	84,000,000	23,000,000	107,000,000	125,000,000	68,000,000	121,000,000	83,000,000	30,000,000	92,000,000	66,000,000	85,000,000	126,000,000	112,000,000	112,000,000	154,000,000	122,000,000	159,000,000	150,000,000	159,000,000	240,000,000	278,000,000	77,000,000	157,000,000	107,000,000	26,000,000	48,000,000	97,000,000	145,100,000	34,800,000	108,800,000	170,100,000	121,600,000	174,400,000	56,900,000
payments for taxes related to net share settlement of equity awards	-114,000,000	-11,000,000	-4,000,000	-5,000,000	-145,000,000	-31,000,000	-6,000,000	-7,000,000	-134,000,000	-34,000,000	-33,000,000	-8,000,000	-267,000,000	-62,000,000	-7,000,000	-2,000,000	-156,000,000	-3,000,000	-13,000,000	-7,000,000	-52,000,000	-16,000,000	-27,000,000	-5,000,000	-36,000,000	-44,000,000	-2,000,000			-10,000,000	-49,000,000	-11,000,000
net cash from financing activities	806,000,000	-2,332,000,000	431,000,000	-1,588,000,000	1,249,000,000	-1,227,000,000	-972,000,000	-2,697,000,000	3,626,000,000	2,726,000,000	-2,187,000,000	-3,218,000,000	-2,461,000,000	-2,650,000,000	-2,831,000,000	-1,967,000,000	-3,314,000,000	-3,244,000,000	-3,735,000,000	-6,117,000,000	-978,000,000	2,675,000,000	-1,440,000,000	-2,968,000,000	-4,258,000,000	816,000,000	-2,693,000,000	-520,000,000	38,140,000,000	-1,786,000,000	-1,502,000,000	-4,133,000,000	-2,442,000,000	-1,666,000,000	-2,460,000,000	9,743,000,000	-761,000,000	-2,406,000,000	-1,775,000,000	-1,423,000,000	-935,000,000	-850,000,000	-751,000,000	-897,000,000			-1,545,000,000			-832,000,000	-912,000,000	-109,000,000	-702,000,000	-564,800,000			-632,400,000	-184,500,000	-176,200,000	1,736,100,000
net increase in cash, cash equivalents and restricted cash	1,679,000,000	1,462,000,000	1,744,000,000	-5,680,000,000	2,713,000,000	1,582,000,000	-4,850,000,000	-752,000,000	-828,000,000	1,650,000,000	-4,258,000,000				-266,000,000	2,707,000,000	1,426,000,000	-2,219,000,000	-1,402,000,000	-5,613,000,000	4,808,000,000	4,383,000,000	485,000,000	-869,000,000	170,000,000	1,873,000,000	-2,230,000,000	1,793,000,000	40,364,000,000
cash, cash equivalents and restricted cash at the beginning of the period	0	8,884,000,000	0	0	0	8,525,000,000	0	0	0	13,305,000,000	0	0	0	12,691,000,000	2,913,000,000	0	0	8,130,000,000	0	0	0	5,954,000,000	0	0	0	4,295,000,000	0	0	1,900,000,000
cash, cash equivalents and restricted cash at the end of the period	1,679,000,000	10,346,000,000	1,744,000,000	-5,680,000,000	2,713,000,000	10,107,000,000	-4,850,000,000	-752,000,000	-828,000,000	14,955,000,000	-4,258,000,000	5,100,000,000	852,000,000	11,611,000,000	2,647,000,000	2,707,000,000	1,426,000,000	5,911,000,000	-1,402,000,000	-5,613,000,000	4,808,000,000	10,337,000,000	485,000,000	-869,000,000	170,000,000	6,168,000,000	-2,230,000,000	1,793,000,000	42,264,000,000
proceeds from sale of subsidiaries											679,000,000	15,000,000
proceeds from issuance of short-term loan							0	0
repayment of short-term loan							0	0
cash paid for prescriptions dispensed and health services rendered									-51,095,000,000	-50,223,000,000
cash paid for inventory and prescriptions dispensed by retail network pharmacies											-50,981,000,000	-47,898,000,000	-46,522,000,000	-44,365,000,000	-43,654,000,000	-42,813,000,000	-40,145,000,000	-39,171,000,000	-42,046,000,000	-40,209,000,000	-39,412,000,000	-36,969,000,000	-39,697,000,000	-39,391,000,000	-34,922,000,000	-35,645,000,000	-37,820,000,000	-36,305,000,000	-36,195,000,000	-37,040,000,000	-37,570,000,000	-36,178,000,000	-35,520,000,000	-35,276,000,000	-35,575,000,000	-31,401,000,000	-29,853,000,000	-28,276,000,000	-26,799,000,000	-26,302,000,000	-23,966,000,000	-23,169,000,000	-22,387,000,000	-22,270,000,000			-22,515,000,000			-17,445,000,000	-17,567,000,000	-17,805,000,000	-17,581,000,000
proceeds from sale-leaseback transactions																																				0	9,000,000	25,000,000	323,000,000	0	5,000,000							0	0	11,000,000				245,100,000	127,300,000	64,300,000	5,300,000	13,800,000	13,800,000	9,900,000
derivative settlements																			0				0				0	0	446,000,000																						0
net decrease in cash, cash equivalents and restricted cash													852,000,000	-1,080,000,000
net borrowings of short-term debt																		252,000,000				255,000,000
proceeds from sale of subsidiary																											0	0	725,000,000																0	0	7,000,000
net repayments of short-term debt
proceeds from sale of subsidiaries and other assets
effect of exchange rate changes on cash, cash equivalents and restricted cash
proceeds from sale of subsidiary and other assets
net borrowings (repayments) of short-term debt																										2,285,000,000
interest received																											212,000,000	144,000,000	50,000,000	5,000,000	4,000,000	6,000,000	5,000,000	4,000,000	5,000,000	6,000,000	6,000,000	3,000,000	5,000,000	3,000,000	3,000,000	3,000,000	1,000,000	1,000,000	1,000,000	0	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,000,000	1,100,000	4,300,000	3,800,000	6,300,000	8,000,000	7,900,000	7,700,000
proceeds from sale of property and equipment and other assets																											4,000,000	5,000,000	2,000,000	7,000,000	8,000,000	5,000,000	11,000,000	9,000,000	2,000,000	14,000,000	6,000,000	8,000,000
acquisitions (net of cash acquired) and other investments																											-83,000,000	-205,000,000	-368,000,000	-187,000,000	-205,000,000	-110,000,000	-165,000,000	-117,000,000	-51,000,000	-9,391,000,000	-51,000,000	-61,000,000	-144,000,000	-54,000,000	-2,194,000,000	-54,000,000	-46,000,000	-254,000,000			-74,000,000			-11,000,000					-13,900,000			-19,900,000
purchase of available-for-sale investments																											-21,000,000	-18,000,000	-18,000,000				-1,000,000	-3,000,000	-36,000,000	-60,000,000	-11,000,000	-113,000,000	0	-118,000,000	-43,000,000
maturities of available-for-sale investments																											6,000,000	27,000,000	10,000,000	5,000,000
decrease in short-term debt																											0	0	-1,276,000,000			-106,000,000						-185,000,000					-300,000,000	-390,000,000			-750,000,000
reconciliation of net income to net cash from operating activities:
net income																											1,390,000,000	-2,563,000,000	998,000,000	1,285,000,000	1,098,000,000	953,000,000	1,541,000,000	924,000,000	1,147,000,000	1,247,000,000	1,272,000,000	1,221,000,000	948,000,000	1,246,000,000	1,129,000,000	1,254,000,000	1,121,000,000	956,000,000	1,006,000,000	965,000,000	775,000,000	867,000,000	815,000,000	712,000,000	808,000,000	821,000,000	770,000,000
adjustments required to reconcile net income to net cash from operating activities:
depreciation and amortization																											620,000,000	647,000,000	644,000,000	615,000,000	623,000,000	619,000,000	611,000,000	619,000,000	617,000,000	532,000,000	488,000,000	490,000,000	477,000,000	488,000,000	477,000,000	461,000,000	449,000,000	502,000,000	443,000,000	431,000,000	423,000,000	407,000,000	391,000,000	374,000,000	370,000,000	368,000,000	358,000,000	300,300,000	310,900,000	310,000,000	299,300,000	301,700,000	308,000,000	208,800,000
goodwill impairments																											0
losses on settlements of defined benefit pension plans
stock-based compensation																											62,000,000	55,000,000	55,000,000	65,000,000	53,000,000	55,000,000	59,000,000	50,000,000	57,000,000	87,000,000	44,000,000	44,000,000	44,000,000	42,000,000	35,000,000	35,000,000	32,000,000	34,000,000	33,000,000	28,000,000	36,000,000	35,000,000	29,000,000	36,000,000	37,000,000	38,000,000	37,000,000
deferred income taxes and other noncash items																											44,000,000	190,000,000	62,000,000	250,000,000	7,000,000	14,000,000	44,000,000	58,000,000	17,000,000	-190,000,000	37,000,000	-31,000,000	-108,000,000	28,000,000	16,000,000	47,000,000	16,000,000	66,000,000	4,000,000	62,000,000	21,000,000
change in operating assets and liabilities, net of effects from acquisitions:
accounts receivable																											-666,000,000	-202,000,000	-857,000,000	-166,000,000	-162,000,000	48,000,000	-435,000,000	-148,000,000	-1,131,000,000	-1,319,000,000	-730,000,000	-481,000,000	-1,288,000,000	-445,000,000	-139,000,000	-943,000,000	-462,000,000	-113,000,000			-70,000,000			-423,000,000	-10,000,000	48,000,000	308,000,000	-185,200,000	-341,600,000	165,700,000	-43,800,000	-229,300,000	367,600,000	198,900,000
inventories																											103,000,000	-95,000,000	464,000,000	128,000,000	36,000,000	456,000,000	-170,000,000	-256,000,000	89,000,000	-428,000,000	-152,000,000	-313,000,000	-214,000,000	-171,000,000	-64,000,000	-243,000,000	11,000,000	193,000,000			-776,000,000	-268,000,000	70,000,000	514,000,000	-196,000,000	-114,000,000	68,000,000	-577,000,000	-344,000,000	-11,900,000	18,800,000	-142,500,000	-321,000,000	130,100,000
other current assets																											161,000,000	-101,000,000	56,000,000	-181,000,000	43,000,000	-74,000,000	172,000,000	-276,000,000	106,000,000	460,000,000	-138,000,000	269,000,000	-86,000,000	-144,000,000	70,000,000	11,000,000	-73,000,000	238,000,000	171,000,000	-32,000,000	286,000,000			-30,000,000	-10,000,000	8,000,000	-39,000,000	19,200,000	-12,600,000	-34,400,000	4,100,000	-1,400,000	900,000	-20,800,000
other assets																											10,000,000	-16,000,000	-113,000,000	23,000,000			-33,000,000	-1,000,000	-52,000,000	35,000,000	4,000,000	-52,000,000	4,000,000	16,000,000	-39,000,000	13,000,000	-3,000,000	-135,000,000			-189,000,000			-52,000,000	15,000,000			-4,400,000	-5,200,000	7,200,000	3,100,000	-12,000,000	-23,200,000	10,100,000
accounts payable and claims and discounts payable																											794,000,000	1,223,000,000	-178,000,000	150,000,000	719,000,000	-539,000,000	406,000,000	366,000,000	798,000,000	655,000,000	627,000,000	756,000,000	701,000,000	182,000,000	339,000,000	599,000,000	328,000,000	-230,000,000				-6,000,000	187,000,000	535,000,000	174,000,000	-171,000,000	-115,000,000	292,300,000	179,900,000	-353,700,000	-190,900,000			-188,300,000
accrued expenses																											-1,484,000,000	-88,000,000	1,231,000,000	325,000,000	-503,000,000	1,848,000,000	1,585,000,000	-249,000,000	741,000,000	764,000,000	-394,000,000	153,000,000	643,000,000	-329,000,000	362,000,000	444,000,000	-517,000,000	105,000,000	-770,000,000	-155,000,000	1,250,000,000	926,000,000	-102,000,000	156,000,000	50,000,000	-282,000,000	-335,000,000	-50,000,000	213,100,000	-226,600,000	-108,000,000	-52,200,000	-287,300,000	-47,800,000
other long-term liabilities																											63,000,000			-70,000,000	-13,000,000	154,000,000	44,000,000	-18,000,000	23,000,000	-23,000,000	-21,000,000	-72,000,000	3,000,000	-16,000,000	-14,000,000	25,000,000	0	24,000,000			-14,000,000			-26,000,000	-9,000,000	-38,000,000	6,000,000	44,100,000	-14,800,000	4,500,000	-1,900,000	-9,800,000	14,000,000	5,700,000
increase in short-term debt																														-990,000,000			-405,000,000			-1,488,000,000															-468,000,000	1,337,000,000	200,000,000
purchase of noncontrolling interest in subsidiary																																	0	0	-39,000,000
payment of contingent consideration
effect of exchange rate changes on cash and cash equivalents																																	0	1,000,000	1,000,000	-7,000,000	-4,000,000	3,000,000	-1,000,000			7,000,000
net decrease in cash and cash equivalents																														391,000,000	-123,000,000	-1,154,000,000		-652,000,000	-680,000,000		-274,000,000	-963,000,000															-39,000,000
cash and cash equivalents at the beginning of the period																														0	0	3,371,000,000
cash and cash equivalents at the end of the period																														391,000,000	-123,000,000	2,217,000,000
goodwill impairment																														0
loss on early extinguishment of debt																																	101,000,000
maturity of available-for-sale investments																																8,000,000
sales/maturities of available-for-sale investments																																	9,000,000	17,000,000	50,000,000	75,000,000	24,000,000	16,000,000	16,000,000	48,000,000	55,000,000
excess tax benefits from stock-based compensation																																	9,000,000	36,000,000	27,000,000	35,000,000	38,000,000	59,000,000	24,000,000	28,000,000	37,000,000	14,000,000	21,000,000	13,000,000	13,000,000						0	2,000,000	11,000,000
net increase in cash and cash equivalents																																									-1,323,000,000	331,000,000	-377,000,000	176,000,000	-590,000,000	-388,000,000	798,000,000	-521,000,000	66,000,000	735,000,000							-238,400,000		101,600,000	180,000,000
cash and cash equivalents at beginning of period																																	0	0	2,459,000,000	0	0	2,481,000,000	0	0	4,089,000,000	0	0	1,375,000,000	0	0	1,413,000,000	0	0	1,427,000,000	0	0	1,086,000,000	0	0	0	1,056,600,000	0	0	530,700,000
cash and cash equivalents at end of period																																	1,062,000,000	-652,000,000	1,779,000,000	1,646,000,000	-274,000,000	1,518,000,000	-480,000,000	-1,154,000,000	2,766,000,000	331,000,000	-377,000,000	1,551,000,000	-590,000,000	-388,000,000	2,211,000,000	-521,000,000	66,000,000	2,162,000,000	-128,000,000	60,000,000	1,047,000,000	-94,700,000	666,600,000	-202,500,000	818,200,000	-85,200,000	101,600,000	710,700,000
adjustments to reconcile net income to net cash from operating activities:
proceeds from sale of property and equipment																																							1,000,000	2,000,000	5,000,000	2,000,000	6,000,000	5,000,000						12,000,000
accounts payable																																														-389,000,000	1,044,000,000
purchase of short-term investments
maturity of short-term investments																																																1,000,000			0	0	1,000,000
deferred income taxes and other non-cash items																																																5,000,000	59,000,000	70,000,000	63,000,000	-22,000,000	2,000,000	9,000,000	32,200,000	-6,500,000	-1,600,000			-20,200,000
change in operating assets and liabilities, net of effects of acquisitions:
cash receipts from revenues																																																	24,979,000,000	22,971,000,000	22,779,000,000	22,827,000,000	22,918,000,000	17,706,900,000	14,510,500,000	14,482,000,000	16,321,600,000	15,655,700,000	15,753,200,000	12,861,000,000
additions to property and equipment																																																			-513,000,000	-465,000,000	-401,000,000	-661,200,000	-527,900,000	-555,000,000	-400,300,000	-454,700,000	-466,100,000	-311,900,000
proceeds from sale or disposal of assets																																																			14,000,000	-2,000,000	12,000,000	500,000	4,100,000	4,700,000	4,800,000	18,600,000	72,900,000	13,200,000
acquisitions (net of cash acquired) and investments																																																			-133,000,000	-16,000,000	-9,000,000	-17,000,000			15,900,000			-1,975,000,000
issuance of long-term debt
decrease in long-term debt																																																					-1,000,000
cash paid for inventory																																																						-12,700,900,000	-10,296,000,000	-9,968,300,000	-12,459,800,000	-13,175,900,000	-12,350,200,000	-9,486,700,000
sale of short-term investments
net reduction in short-term debt
sale of short-term investment																																																									27,500,000
net reductions in short-term debt
excess tax benefits from stock based compensation																																																							3,100,000	25,100,000	27,100,000	18,700,000	22,400,000	7,700,000
additions to long-term debt																																																										0	5,500,000,000	500,000,000
reductions to long-term debt
reconciliation of net earnings to net cash from operating activities:
net earnings																																																							736,000,000	774,800,000	748,500,000	689,500,000	723,600,000	408,900,000
adjustments required to reconcile net earnings to net cash from operating activities:
stock based compensation																																																							32,300,000	22,200,000	13,200,000	12,300,000	24,700,000	22,300,000
change in operating assets and liabilities, providing/(requiring) cash, net of effects from acquisitions:
reductions in long-term debt																																																							-700,000	-700,000	-600,000	-500,000	-502,300,000	-18,300,000
reductions in short-term debt																																																							2,000,000
net cash (used in)/provided by financing activities																																																							290,800,000
sale/(purchase) of short-term investments
net (decrease)/increase in cash and cash equivalents
(reductions in) additions to short-term debt																																																									-743,100,000
cash outflow from hedging activities
(reductions in)/additions to short-term debt																																																										-235,400,000
net increase/(decrease) in cash and cash equivalents
accounts and claims and discounts payable
purchase of short-term investment
additions to short-term debt																																																												1,230,100,000

We provide you with 20 years of cash flow statements for CVS Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CVS Health stock. Explore the full financial landscape of CVS Health stock with our expertly curated income statements.

The information provided in this report about CVS Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.